Czasopismo Przegląd Menopauzalny 2023

Ahmed Elsayad, Wael Khafagy, Walaa ElBassioune, Mahmoud Rady, Ahmed Abdeltawab, Muhammad Altoraky, Mahmoud Hegazy, Waled Ayad, Moatazza Alghazaly, Ahmed Elshorbagy, Ahmed Shafik Almorsy, Ahmed Saeed, Elmetwally Farouk, Ehab Elhelw, Hamada Abuelmatti, Mohammed El-Husseny Elkadosi

Menopause Rev 2023; 22(2): 83-86

DOI: https://doi.org/10.5114/pm.2023.127964

Abstract View text (PDF)

Review paper

Early-stage cervical cancer treatment – what’s new?

Camilla Di Dio, Ilham Azenkoud, Angelo Trezza, Emanuele Lentini, Tullio Golia D’Augè, Ilaria Cuccu, Giorgia Di Bartolomeo, Ilaria Firulli, Andrea Canicchio, Ludovica Sgamba, Ludovico Muzii

Menopause Rev 2023; 22(2): 87-92

DOI: https://doi.org/10.5114/pm.2023.127774

Abstract View text (PDF)

Review paper

Epidemiology and risk factors for ovarian cancer

Aus Tariq Ali, Osamah Al-ani, Faisal Al-ani

Menopause Rev 2023; 22(2): 93-104

DOI: https://doi.org/10.5114/pm.2023.128661

Abstract View text (PDF)

Case report

The burden of paraovarian cysts – a case series and review of the literature

Sweta Singh, Ishita Agarwal, Jasmina Begum, Bhavya Bhardwaj

Menopause Rev 2023; 22(2): 105-110

DOI: https://doi.org/10.5114/pm.2023.128054

Abstract View text (PDF)

Case report

A rare case of angiomyomatous hamartoma in the pelvic and paraaortic lymph nodes

Angel Yordanov, Tatyana Betova, Savelina Popovska, Stoyan Kostov, Yavor Kornovski, Yonka Ivanova, Stanislav Slavchev, Ilko Iliev, Venelina Todorova

Menopause Rev 2023; 22(2): 111-116

DOI: https://doi.org/10.5114/pm.2023.128062

Abstract View text (PDF)

Letter to the Editor

Response to paper by Binkowska et al. Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings. Commentary: Oestradiol is not the holy grail in the quest for the ideal oestrogen therapy

Jonathan Douxfils, Jean-Michel Foidart, Ulysse Gaspard, Guillaume Chatel, Mélanie Taziaux, Maud Jost, Céline Gérard, Laure Morimont

Menopause Rev 2023; 22(2): 117-119

DOI: https://doi.org/10.5114/pm.2023.128815

View text (PDF)

The pathogenic pathways of cardiovascular disease in perimenopausal women

Communication skills training with the transactional analysis approach developed menopausal women’s marital adjustment – a quasi-experimental study

The shift in COVID-19 vaccination policy for pregnant women, from restricted to required, and the confusion that ensued

Effect of intrauterine infusion of autologous platelet-rich plasma in patients with refractory thin endometrium undergoing in vitro fertilization

A paradigm of higher success rate of intracytoplasmic sperm injection – preovulatory human chorionic gonadotropin-day serum oestradiol

Early-stage cervical cancer treatment – what’s new?

Epidemiology and risk factors for ovarian cancer

The burden of paraovarian cysts – a case series and review of the literature

A rare case of angiomyomatous hamartoma in the pelvic and paraaortic lymph nodes

Response to paper by Binkowska et al. Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings. Commentary: Oestradiol is not the holy grail in the quest for the ideal oestrogen therapy

Coverage in

Indexed in

Integrated with

Editorial Policies